US6392071B1
(en)
*
|
1997-03-17 |
2002-05-21 |
Wisconsin Alumni: Research Foundation |
26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
|
US5945410A
(en)
*
|
1997-03-17 |
1999-08-31 |
Wisconsin Alumni Research Foundation |
2-alkyl-19-nor-vitamin D compounds
|
US6316642B1
(en)
*
|
1997-03-17 |
2001-11-13 |
Wisconsin Alumni Research Foundation |
26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
|
MA26481A1
(fr)
*
|
1997-04-21 |
2004-12-20 |
Hoffmann La Roche |
Derives d'arylsecocholadiene
|
US5936105A
(en)
*
|
1997-06-13 |
1999-08-10 |
Tetrionics, Inc. |
14-EPI-19-nor-vitamin D compounds and methods
|
US20030188756A1
(en)
*
|
2002-08-19 |
2003-10-09 |
Cantorna Margherita T |
Treatment of inflammatory bowel disease with vitamin d compounds
|
US6359012B1
(en)
*
|
1999-12-22 |
2002-03-19 |
Bone Care International, Inc. |
Method for making 24(S)-hydroxyvitamin D2
|
JP4022141B2
(ja)
*
|
2000-05-31 |
2007-12-12 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
2−エチル及び2−エチリデン−19−ノル−ビタミンd化合物
|
JP2004505022A
(ja)
*
|
2000-07-14 |
2004-02-19 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
骨強度を増加するための2−メチレン−19−ノル−20(S)−1α,25−ジヒドロキシビタミンD3の使用
|
BR0113703A
(pt)
*
|
2000-09-08 |
2003-07-22 |
Wisconsin Alumni Researcg Foun |
Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele
|
BR0207975A
(pt)
*
|
2001-03-15 |
2004-06-15 |
Basf Ag |
Composto, processo para preparar 5 fenilpiridinas, produto intermediário, agente adequado para combater fungos nocivos fitopatogênicos, e, processo para combater fungos nocivos fitopatogênicos
|
US6683219B2
(en)
|
2001-07-30 |
2004-01-27 |
Wisconsin Alumni Research Foundation |
Synthesis of A-ring synthon of 19-nor-1α,25-dihydroxyvitamin D3 from (D)-glucose
|
PT1453798E
(pt)
*
|
2001-12-13 |
2009-01-23 |
Wisconsin Alumni Res Found |
(20s)-1alfa-hidroxi-2-metileno-19-nor-bishomopregnacalciferol e suas utilizações
|
US6627622B2
(en)
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
US6835723B2
(en)
*
|
2001-12-13 |
2004-12-28 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
|
US6566352B1
(en)
|
2002-02-18 |
2003-05-20 |
Wisconsin Alumni Research Foudation |
1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
|
US6964784B2
(en)
*
|
2002-03-07 |
2005-11-15 |
Optigenex, Inc. |
Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
|
US20030195175A1
(en)
*
|
2002-03-25 |
2003-10-16 |
Deluca Hector F. |
Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
|
CA2477543C
(en)
*
|
2002-03-29 |
2011-01-04 |
Wisconsin Alumni Research Foundation |
Method of synthesizing 1.alpha.-hydroxy-2-methylene-19-nor-homopregnacalciferol
|
US6846811B2
(en)
*
|
2002-04-22 |
2005-01-25 |
Wisconsin Alumni Research Foundation |
(20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
|
US7259143B2
(en)
*
|
2002-09-05 |
2007-08-21 |
Wisconsin Alumni Research Foundation |
Method of extending the dose range of vitamin D compounds
|
US20080249068A1
(en)
*
|
2002-09-05 |
2008-10-09 |
Deluca Hector F |
Method of Extending the Dose Range of Vitamin D Compounds
|
EP1598360A4
(de)
|
2003-02-25 |
2010-04-07 |
Knc Lab Co Ltd |
Neue zwischenprodukte für die synthese von vitamin-d-derivaten
|
CN101293894B
(zh)
*
|
2003-04-10 |
2011-04-06 |
威斯康星校友研究基金会 |
制备2-亚丙基-19-去甲维生素d化合物的中间体
|
EP1641466B1
(de)
*
|
2003-07-03 |
2007-01-03 |
Wisconsin Alumni Research Foundation |
2-methylen-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol und seine verwendungen
|
US6894037B2
(en)
*
|
2003-07-03 |
2005-05-17 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
|
US20050009792A1
(en)
*
|
2003-07-08 |
2005-01-13 |
Deluca Hector F. |
(20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses
|
US20050209203A1
(en)
*
|
2003-07-30 |
2005-09-22 |
Jin Tian |
Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
|
NZ545862A
(en)
*
|
2003-08-20 |
2010-01-29 |
Wisconsin Alumni Res Found |
2-Methylene-19-nor-vitamin D2 compounds
|
MXPA06003063A
(es)
*
|
2003-09-19 |
2006-05-31 |
Pfizer Prod Inc |
Composiciones farmaceuticas y metodos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina- d y un bisfosfonato.
|
WO2005027916A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and aromatase inhibitors
|
WO2005027918A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a cyclooxgenase-2 inhibitor
|
WO2005027929A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen
|
WO2005027913A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
|
WO2005027920A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of rickets or vitamin d deficiency
|
JP2007505884A
(ja)
*
|
2003-09-19 |
2007-03-15 |
ファイザー・プロダクツ・インク |
骨減少症又は男性の骨粗しょう症の治療のための2−アルキリデン−19−ノル−ビタミンd誘導体
|
AU2004273660B2
(en)
*
|
2003-09-19 |
2010-08-19 |
Wisconsin Alumni Research Foundation (Warf) |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone
|
AU2004273658A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Wisconsin Alumni Research Foundation (Warf) |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
|
WO2005027931A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
|
WO2005027925A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of anorexia or low bone mass in females exhibiting aggressive athletic behavior
|
WO2005027919A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
|
WO2005027927A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for enhancement of peak bone mass in adolescence
|
WO2005027926A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bone morphogenetic protein
|
EP1667688A1
(de)
*
|
2003-09-19 |
2006-06-14 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d-derivate zur behandlung von gebrechlichkeit, muskelschädigung oder sarcopenie
|
WO2005027928A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vit amin d derivatives for the treatment of hypocalcemic tetany or hyproparathyroidism
|
WO2005027930A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylene-19-nor-vitamin d derivatives for the treatment of osteosarcoma
|
WO2005027922A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Pfizer Products Inc. |
2-alkylidene-19-nor-vitamin d derivatives for the treatment of hypogonadism or andropause
|
US7214670B2
(en)
*
|
2003-09-24 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
|
US7704980B2
(en)
*
|
2003-10-08 |
2010-04-27 |
Wisconsin Alumni Research Foundation |
Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
|
WO2005051323A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Wisconsin Alumni Research Foundation |
Vitamin d analogs for obesity prevention and treatment
|
WO2005051396A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Deltanoid Pharmaceuticals, Inc. |
Methods for reducing body fat using vitamin d compounds
|
US7915242B2
(en)
*
|
2004-02-17 |
2011-03-29 |
Wisconsin Alumni Research Foundation |
Vitamin D receptor antagonists and their use in treating asthma
|
US7214671B2
(en)
|
2004-02-19 |
2007-05-08 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
|
US7713951B2
(en)
*
|
2004-04-09 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-alkylidene-18,19-dinor-vitamin D compounds
|
CA2586679A1
(en)
|
2004-11-12 |
2006-05-18 |
Bioxell Spa |
Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
|
EP1817278B1
(de)
*
|
2004-11-22 |
2010-06-30 |
Wisconsin Alumni Research Foundation |
2-methylen-18,19-dinor-1alfa-hydroxy-homopregnacalciferol und dessen verwendungen
|
JP2008520709A
(ja)
*
|
2004-11-22 |
2008-06-19 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−19−ノル−(20S)−1α−ヒドロキシ−トリスホモプレグナカルシフェロール
|
EP1817279B1
(de)
*
|
2004-11-22 |
2010-05-26 |
Wisconsin Alumni Research Foundation |
17,20(z)-dehydro-vitamin-d-analoge und deren verwendungen
|
MX2007006090A
(es)
*
|
2004-11-22 |
2007-07-11 |
Wisconsin Alumni Res Found |
2-metilen-19-nor-(20r)-1a-hidroxi-bishomopregnacalciferol.
|
AU2005309820B2
(en)
*
|
2004-11-22 |
2011-06-23 |
Wisconsin Alumni Research Foundation |
2-methylene-19,21-dinor-1alpha-hydroxy-bishomopregnacalciferol
|
NZ555281A
(en)
*
|
2004-11-22 |
2011-01-28 |
Wisconsin Alumni Res Found |
2-methylene-19,26,27-trinor-(20s)-1alpha-alpha-hydroxyvitamin D3 and its uses
|
US8399438B2
(en)
*
|
2004-11-22 |
2013-03-19 |
Wisconsin Alumni Research Foundation |
2α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and its uses
|
US7511030B2
(en)
*
|
2005-02-11 |
2009-03-31 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(20S-24epi)-1α,25-dihydroxyvitamin D2
|
JP5036566B2
(ja)
*
|
2005-02-11 |
2012-09-26 |
ウイスコンシン アラムニ リサーチ ファンデーション |
2−メチレン−19−ノル−(20S−24S)−1α,25−ジヒドロキシビタミン−D2
|
US7235680B2
(en)
*
|
2005-03-29 |
2007-06-26 |
Wisconsin Alumni Research Foundation |
2-methylene-19-nor-(23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone
|
NZ563758A
(en)
*
|
2005-05-03 |
2010-04-30 |
Wisconsin Alumni Res Found |
19,26,27-Trinor-1alpha,25-dihydroxyvitamin D3 compounds
|
JP5090355B2
(ja)
*
|
2005-08-30 |
2012-12-05 |
ウイスコンシン アラムニ リサーチ ファンデーション |
1α,25−ジヒドロキシ−19−ノルビタミンD3のデス−C,D類縁体
|
CA2623481A1
(en)
*
|
2005-09-22 |
2007-04-05 |
Wisconsin Alumni Research Foundation |
19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3
|
US7803789B2
(en)
*
|
2006-02-02 |
2010-09-28 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—RAK, methods and uses thereof
|
US7528122B2
(en)
*
|
2006-02-02 |
2009-05-05 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—NEL, methods and uses thereof
|
MX2008012701A
(es)
*
|
2006-04-05 |
2009-01-07 |
Wisconsin Alumni Res Found |
Compuestos de 1-alfa-hidroxi-2-(3'-hidroxipropiliden)-19-nor-vitam ina d y metodos de elaboracion y tratamiento de los mismos.
|
US20090281340A1
(en)
*
|
2006-04-05 |
2009-11-12 |
Deluca Hector F |
1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and treatment thereof
|
JP2009532459A
(ja)
*
|
2006-04-06 |
2009-09-10 |
ウイスコンシン アラムニ リサーチ ファンデーション |
1,2または3,2複素環を有する19−ノル−ビタミンdアナログ
|
MX2008012913A
(es)
*
|
2006-04-06 |
2009-03-06 |
Wisconsin Alumni Res Found |
2-metilen-1a,25-dihidroxi-18,19,21-trinorvitamina d3 y sus usos.
|
CA2646909A1
(en)
*
|
2006-04-06 |
2008-03-27 |
Hector F. Deluca |
2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
|
EP2046737B1
(de)
*
|
2006-04-06 |
2011-09-07 |
Wisconsin Alumni Research Foundation |
2-methylen-1-alpha-dihydroxy-19,21-dinor-vitamin-d3-analoga und ihre anwendung
|
CA2646911A1
(en)
*
|
2006-04-06 |
2008-03-27 |
Hector F. Deluca |
2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof
|
CA2645185A1
(en)
*
|
2006-04-06 |
2008-03-27 |
Wisconsin Alumni Research Foundation |
2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
|
US8193169B2
(en)
*
|
2006-04-06 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
(20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
|
CA2648521A1
(en)
*
|
2006-04-10 |
2008-02-28 |
Wisconsin Alumni Research Foundation |
1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-n0r-vitamin d compounds with a 1,1-dimethylpropyl side chain
|
WO2008039754A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Wisconsin Alumni Research Foundation |
2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
|
WO2008039751A2
(en)
*
|
2006-09-28 |
2008-04-03 |
Wisconsin Alumni Research Foundation |
2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
|
WO2008089093A2
(en)
*
|
2007-01-12 |
2008-07-24 |
Quatrx Pharmaceuticals Company |
Efficient processes for preparing steroids and vitamin d derivatives with the unnatural configuration at c20 (20 alpha-methyl) from pregnenolone
|
MX2010007263A
(es)
*
|
2007-12-28 |
2011-03-15 |
Wisconsin Alumni Res Foundation Star |
Análogos de vitamina d-2-metilen-(20s, 25s)-19, 26-dinor.
|
WO2009086436A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Wisconsin Alumni Research Foundation |
(20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
|
JP2011508744A
(ja)
*
|
2007-12-28 |
2011-03-17 |
ウィスコンシン アラムナイ リサーチ ファンデーション |
(20r)−23,23−ジフルオロ−2−メチレン−19−ノル−ビスホモプレグナカルシフェロール−ビタミンd類縁体
|
AU2008345084A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Wisconsin Alumni Research Foundation |
2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs
|
AU2008345086B2
(en)
*
|
2007-12-28 |
2014-02-13 |
Wisconsin Alumni Research Foundation |
2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin D analogs
|
MX2010007956A
(es)
*
|
2008-01-22 |
2010-09-14 |
Wisconsin Alumni Reasearch Fou |
Analogos de 13,13-dimetil-des-c,d de compuestos de 1a,25-dihidroxi-19-nor-vitamina d3 y formas de dosificacion de composicion topica y metodos de tratamiento de condiciones de la piel.
|
US8193170B2
(en)
|
2008-07-10 |
2012-06-05 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
|
US8222236B2
(en)
*
|
2008-07-10 |
2012-07-17 |
Wisconsin Alumni Research Foundation |
2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
|
US7893043B2
(en)
*
|
2008-07-10 |
2011-02-22 |
Wisconsin Alumni Research Foundation |
2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
|
US7648974B1
(en)
*
|
2008-07-10 |
2010-01-19 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 3,2-dihydrofuran ring
|
US7888339B2
(en)
|
2008-07-10 |
2011-02-15 |
Wisconsin Alumni Research Foundation |
2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
|
US7713953B2
(en)
*
|
2008-07-10 |
2010-05-11 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
US8399439B2
(en)
|
2008-07-10 |
2013-03-19 |
Wisconsin Alumni Research Foundation |
2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
|
US7879829B2
(en)
*
|
2008-07-10 |
2011-02-01 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D analogs with 1,2-dihydrofuran ring
|
US20120115824A1
(en)
*
|
2009-04-17 |
2012-05-10 |
Vidasym, Llc |
Vitamin D Receptor Agonists and Uses Thereof
|
WO2011017165A1
(en)
|
2009-08-03 |
2011-02-10 |
Wisconsin Alumni Research Foundation |
Method of preventing renal disease and treating symptoms thereof
|
AU2010300539B9
(en)
*
|
2009-10-02 |
2018-07-19 |
Wisconsin Alumni Research Foundation |
1-desoxy-2-methylene-19-nor-vitamin D analogs and their uses
|
WO2011041579A2
(en)
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
(20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS
|
WO2011041596A2
(en)
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin d analogs with 1,2-or 3,2-cyclopentene ring
|
WO2011041599A2
(en)
*
|
2009-10-02 |
2011-04-07 |
Wisconsin Alumni Research Foundation |
6-methylvitamin d3 analogs and their uses
|
EP2490695B1
(de)
|
2009-10-21 |
2013-11-20 |
Wisconsin Alumni Research Foundation |
Verfahren zur vorbeugung der diabetes typ i
|
US8664206B2
(en)
|
2010-03-23 |
2014-03-04 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3
|
JP5770261B2
(ja)
*
|
2010-03-23 |
2015-08-26 |
ウイスコンシン アラムニ リサーチ ファンデーション |
(20S)−2−メチレン−19−ノル−22−ジメチル−1α,25−ジヒドロキシビタミンD3および(20R)−2−メチレン−19−ノル−22−ジメチル−1α,25−ヒドロキシビタミンD3
|
CA2793727C
(en)
|
2010-03-23 |
2017-01-03 |
Wisconsin Alumni Research Foundation |
Diastereomers of 2-methylene-19-nor-22-methyl-1.alpha.,25-dihydroxyvitamin d3
|
AU2011308911B2
(en)
|
2010-09-30 |
2014-10-02 |
Wisconsin Alumni Research Foundation |
(20R,25S)-2-methylene-19,26-dinor-1alpha, 25-dihydroxyvitamin D3 in crystalline form
|
US8754067B2
(en)
|
2010-11-12 |
2014-06-17 |
Wisconsin Alumni Research Foundation |
22-haloacetoxy-homopregnacalciferol analogs and their uses
|
US9290447B2
(en)
|
2011-05-03 |
2016-03-22 |
Wisconsin Alumni Research Foundation |
(20R) and (20S)-24-(p-toluenesulfonyloxy)-25,26,27-trinorvitamin D3 analogs and their uses
|
WO2012158794A1
(en)
|
2011-05-17 |
2012-11-22 |
Wisconsin Alumni Research Foundation |
N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
|
AU2012262174B2
(en)
|
2011-06-03 |
2016-12-01 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin D3 derivatives
|
CA2824870C
(en)
*
|
2011-06-14 |
2018-08-14 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
|
US10479764B2
(en)
|
2011-06-28 |
2019-11-19 |
Wisconsin Alumni Research Foundation |
2-methylene-(22E)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin D analogs
|
WO2013012644A1
(en)
|
2011-07-18 |
2013-01-24 |
Wisconsin Alumni I Research Foundation |
2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs
|
US20130053356A1
(en)
|
2011-08-26 |
2013-02-28 |
Hector F. DeLuca |
2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3
|
US8519169B2
(en)
|
2011-08-30 |
2013-08-27 |
Wisconsin Alumni Research Foundation |
Crystallization a 1alpha-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin D3
|
US8420839B1
(en)
|
2011-10-05 |
2013-04-16 |
Wisconsin Alumni Research Foundation |
Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol
|
CA2851275C
(en)
|
2011-10-21 |
2020-07-14 |
Wisconsin Alumni Research Foundation |
2-methylene-vitamin d analogs and their uses
|
US8729054B2
(en)
|
2011-10-21 |
2014-05-20 |
Wisconsin Alumni Research Foundation |
3-desoxy-2-methylene-vitamin D analogs and their uses
|
EP2768804B1
(de)
*
|
2011-10-21 |
2018-02-28 |
Wisconsin Alumni Research Foundation |
2-methylen-vitamin-d-analoge und ihre verwendungen
|
US8884039B2
(en)
|
2012-05-30 |
2014-11-11 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) and (20S) analogs of 2-methylene-19-nor-24-dimethyl-1α,25-dihydroxyvitamin D3
|
US9040728B2
(en)
|
2012-05-30 |
2015-05-26 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R) 19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US8940916B2
(en)
|
2012-05-30 |
2015-01-27 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R)-2-methylene-19-nor-24-difluoro-1α,25-dihydroxyvitamin D3
|
US9212137B2
(en)
|
2012-05-30 |
2015-12-15 |
Wisconsin Alumni Research Foundation |
Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 and related precursors
|
US8785422B2
(en)
|
2012-06-06 |
2014-07-22 |
Wisconsin Alumni Research Foundation |
A-ring modified 19-nor-vitamin D analogs and their uses
|
JP2015522015A
(ja)
|
2012-06-29 |
2015-08-03 |
ウイスコンシン アラムニ リサーチ ファンデーション |
続発性副甲状腺機能亢進症を治療するための2−メチレン−19−ノル−(20S)−1α,25−ジヒドロキシビタミンD3の使用
|
EP2746252A1
(de)
|
2012-12-21 |
2014-06-25 |
Wisconsin Alumni Research Foundation (WARF) |
Kristallisierung von 1alpha-Hydroxy-2-methylen- 18,19-dinor-homopregnacalciferol
|
US9416102B2
(en)
*
|
2013-01-23 |
2016-08-16 |
Wisconsin Alumni Research Foundation |
(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs
|
US9539264B2
(en)
|
2014-12-30 |
2017-01-10 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics
|
US10369161B2
(en)
|
2014-12-30 |
2019-08-06 |
Wisconsin Alumni Research Foundation |
Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism
|
WO2016191583A1
(en)
|
2015-05-26 |
2016-12-01 |
Wisconsin Alumni Research Foundation |
1α,25-DIHYDROXY-24,24-DIFLUORO-19-NOR-VITAMIN D3 ANALOGS AND THEIR PHARMACEUTICAL USES
|
WO2017184262A1
(en)
|
2016-04-18 |
2017-10-26 |
Wisconsin Alumni Research Foundation |
Use of 2amd and 2md to treat fibrosis
|
WO2018044468A1
(en)
|
2016-08-30 |
2018-03-08 |
Wisconsin Alumni Research Foundation |
COMBINATION OF LOW DOSE 2-METHYLENE-19-NOR-(20S)-1α, 25-DIHYDROXYVITAMIN D3 AND CALCIMIMETICS TO TREAT SECONDARY HYPERPARATHYROIDISM
|